Targeting of HBP1/TIMP3 axis as a novel strategy against breast cancer.
Zhou Y, Zhang T, Wang S, Yang R, Jiao Z, Lu K, Li H, Jiang W, Zhang X.
Zhou Y, et al. Among authors: zhang t, zhang x.
Pharmacol Res. 2023 Aug;194:106846. doi: 10.1016/j.phrs.2023.106846. Epub 2023 Jul 4.
Pharmacol Res. 2023.
PMID: 37414199
Free article.